We examined expression ofthe ES tranform- The significance of these disparate findings to the in vivo activity of BPV-1 is unclear in the absence of data on the site of expression of the E5 protein in virus-induced fibropapilloma tissue. We now present evidence for two physically and temporally remote sites of BPV-1 E5 gene expression within the epithelial layers of naturally infected fibropapilloma tissue, suggesting that the E5 protein may be involved in the early (transforming) phase and in the late (maturation) phase of the BPV-1 replication cycle in keratinocytes.
tival fibroblasts transformed in vitro by experimental infection with purified BPV-1 virions expressed ifcantly higher amounts of the 7-kDa ES protein than BPV-1-transformed murine C127 cells. Indirect immunofluorescence analysis revealed a cytoplasmic, predominantly juxtanudear, locallzation of ES protein in the in vitro virus-transormed bovine cells. In naturally infected bovine skin fibropap oma tissue, two widely separated sites of E5 protein synthesis were identified within the epithelial layers. Transformed basal layer keratinocytes throughout the tumor tissue expressed cytoplasmic ES protein at a low uniform level. In addition, abundant amounts of cytoplasmic E5 protein with a granular staining pattern were detected in highly differentiated keratinocytes in close association with sites of viral capsid protein synthesis. These observations imply roles for the viral E5 oncogene in the growth transformation of basal epidermal keratinocytes as well as in the differentiation-linked process of viral maturation. Detection of a papillomavirus protein in the basal cell population of warts lends support to the hypothesis that these cells are maintained in a transformed state by continuous expression of a viral transforming gene.
Bovine papillomavirus type 1 (BPV-1) is a DNA tumor virus that causes skin fibropapillomas (warts) in cattle (1). These benign tumors are formed by excessive proliferation of virus-infected dermal fibroblasts and epidermal keratinocytes. Viral gene expression and viral DNA replication are coordinated with the process ofterminal differentiation ofthe host epidermal keratinocyte for BPV-1 and for other animal and human papillomaviruses. Papillomavirus DNA amplification and synthesis of capsid proteins are confined to terminally differentiated epidermal cells within wart tissue. The transformed state of the dermal fibroblasts within the fibroma and of the basal layer keratinocytes within the overlying papilloma in BPV-1-induced warts is thought to be maintained by constitutive expression of a viral transforming gene(s) (1, 2). However, detection of a papillomavirus transforming protein in the proliferating transformed cells of a wart has not previously been described.
The early region of the BPV-1 genome contains two separate oncogenes (E5 and E6) that can morphologically transform certain rodent cell lines in vitro (3-6). The mechanism by which the BPV-1 E6 protein induces cell transformation is not known. The E5 protein consists of only 44 amino acid residues and may induce fibroblast transformation by activating one or more cellular growth factor receptors. Martin et al. (7) (9) .
The significance of these disparate findings to the in vivo activity of BPV-1 is unclear in the absence of data on the site of expression of the E5 protein in virus-induced fibropapilloma tissue. We now present evidence for two physically and temporally remote sites of BPV-1 E5 gene expression within the epithelial layers of naturally infected fibropapilloma tissue, suggesting that the E5 protein may be involved in the early (transforming) phase and in the late (maturation) phase of the BPV-1 replication cycle in keratinocytes.
MATERIALS AND METHODS Antirm. Polyclonal E5 antisera were raised in two rabbits against the synthetic peptide Leu-Val-Tyr-Trp-Asp-His-PheGlu-Cys-Ser-Cys-Thr-Gly-Leu-Pro-Phe corresponding to the C-terminal 16-amino acid segment of the BPV-1 E5 protein.
Cell Culture and Immunoprecipitation. Transformation of bovine conjunctival fibroblasts and murine C127 cells by infection with purified BPV-1 virions has been described (10 sodium deoxycholate, 0.1% (wt/vol) SDS, 100 units of trasylol protease inhibitor per ml (Bayer, Wuppertal, F.R.G.), 5 mM MgCl2, and 0.1 mM dithiothreitol] with brief mixing in a Vortex. Cell debris was then removed by centrifugation at 5000 x g, 40C for 2 min. To the supernatant was added 25 pul of anti-E5 antibody or control nonimmune rabbit serum. Following a 2-hr incubation at 40C with continuous mixing by slow rotation, 100 ttl of protein A-Sepharose slurry was added and mixing was continued for 1 hr. The protein A-Sepharose was then pelleted by brief centrifugation and washed three times with RIPA buffer. The sedimented protein A-Sepharose was again resuspended in RIPA buffer, and bound antibody-protein complexes were dissociated at 1000C for 5 min. The protein A-Sepharose was then removed by centrifugation, and the immunoprecipitation and washing steps were repeated. Following the third RIPA wash in the second round of immunoprecipitation, the protein A-Sepharose pellet was resuspended in an equal volume of 2 x gel-loading buffer [100 mM Tris HCl (pH 6.8), 4% (wt/vol) SDS, 0.2% (wt/vol) bromophenol blue, and 20% (vol/vol) glycerol] and heated to 100°C for 5 min prior to electrophoresis on a 15% (wt/vol) polyacrylamide gel containing SDS. Radiolabeled immunoprecipitated proteins were subsequently detected by fluorography as described (12) .
Immunofluorescence Analysis. Bovine skin fibropapillomas from four naturally infected cows and a sample of normal hair-bearing skin from one of the infected cattle were obtained at slaughter from a local abbatoir in the Uppsala district. The tissues were frozen in liquid nitrogen and were stored at -70°C prior to sectioning in a cryostat. Each wart contained BPV-1 DNA, as revealed by restriction endonuclease and DNA hybridization analysis of total tissue DNA isolated from the warts. Indirect immunofluorescence analysis was performed on acetone-fixed thin sections of the skin fibropapillomas as described (12) . Tissue culture cells were fixed in situ on tissue culture plastic with a solution of 4% (wt/vol) paraformaldehyde in PBS, and cells were subsequently made permeable by treatment with 0.1% (vol/vol) Triton X-100 in PBS for 90 sec as described in detail elsewhere (13) . E5 antiserum or preimmune serum were used at a dilution of 1:1000 in PBS. Blocking of E5 antiserum with E5 peptide was done by incubating serum, diluted 1:100 in PBS, with 100 ,ug of E5 synthetic peptide per ml overnight at 4°C. Antisera to BPV-1 E2 (14) and BPV-1 capsids (Dakopatts, Glostrup, Denmark) were used at dilutions of 1:4000 and 1:2000, respectively. The second antibody was fluorescein-conjugated swine anti-rabbit immunoglobulin (Dakopatts), at a dilution of 1:80. Fluorescence was preserved by mounting the cells or tissue sections in Citifluor (City University, London). RESULTS The BPV-1 E5 gene product has been identified as a 7-kDa protein in cells of rodent, monkey, or insect origin expressing the E5 gene from heterologous promoters and in BPV-1-transformed mouse and hamster fibroblasts (15) (16) (17) (18) (19) (20) . By immunoprecipitation analysis with polyclonal rabbit antiserum raised to a chemically synthesized 16-amino acid E5 C-terminal peptide, we compared expression of the E5 protein in murine C127 cells and bovine conjunctival fibroblasts transformed in vitro by infection with purified BPV-1 virions. As shown in Fig. 1 , a single 7-kDa E5 protein species was detected in transformed bovine cells infected with BPV-1 but not in uninfected primary bovine fibroblasts. Virustransformed C127 cells expressed an E5 protein with an identical electrophoretic mobility but in lesser amount (the difference in level of ES expression in the transformed murine and bovine cell cultures was greater than indicated by this autoradiograph, since we compared immunoprecipitated protein from three to four times more mouse cells than bovine By indirect immunofluorescence analysis we detected specific cytoplasmic staining in virus-transformed bovine fibroblasts (Fig. 2 a-d) . In contrast, we failed to detect specific staining in virus-transformed murine C127 cells (Fig. 2h) , indicating that E5 protein expression in these cells was below the level of detection by this method. Extensive controls were done to check the specificity of the immunofluorescence in the bovine cells. (i) Immunofluorescence analysis of control uninfected primary bovine conjunctival fibroblasts with E5 peptide antiserum confirmed that there was no cross-reactivity with a normal cellular cytoplasmic component (Fig. 2e). (ii) No staining of the virus-transformed bovine cells was observed with preimmune serum (Fig. 2g) . (iii) Preincubation of immune serum with purified E5 peptide completely blocked recognition of the cytoplasmic antigen in the virus-transformed bovine cells (Fig. 2f) .
As shown in Fig. 2 a- (Fig. 2c,  arrows) , similar to the juxtanuclear staining pattern interpreted as Golgi-specific localization described for murine BALB/c 3T3 or simian COS cells expressing the BPV-1 E5 protein from strong heterologous promoters (16, 17) . Less frequently, cells were observed either with fluorescent spots distributed extensively throughout the cytoplasm (Fig. 2 a  and d, arrows) or with a homogeneous diffuse staining of the cytoplasm in combination with strong juxtanuclear or perinuclear fluorescence (Fig. 2b, arrows) . A fraction of cells (20-30%) within the transformed bovine cell cultures did not contain detectable ES antigen.
To examine the site of expression of the ES protein in naturally infected cells, we performed indirect immunofluorescence analysis on thin cryostat sections of bovine fibropapilloma tissue prepared from four cases of BPV-1-induced warts obtained from different cattle. Preimmune serum and E5 peptide-blocked immune serum were used as controls. In addition, BPV-1 E2 antiserum (14) and BPV-1 capsid antiserum (Dakopatts) were used as positive control sera. All sera were tested on the fibropapilloma tissue and on normal uninfected bovine skin tissue.
Two sites of E5 protein expression were identified within the fibropapilloma. Keratinocytes in the basal layer throughout the wart tissue were uniformly positive when tested with the E5 antiserum. The transformed basal layer keratinocytes were observed as a thin rim of positively stained cells surrounding the hypertrophic dermal papillae, as shown at low magnification in Fig. 3a (arrows) and at high magnification in Fig. 3 c-e. Basal layer cells in normal bovine skin did not stain with E5 antiserum (Fig. 3f) . The specificity of the immunofluorescent staining in the wart tissues was further confirmed by the absence of staining of the basal layer cells with preimmune serum (Fig. 3 b and g ) or with E5 peptideblocked immune serum (Fig. 3h) (Fig. 4 a and b) . Comparison of several parallel tissue sections stained with E5 or capsid antisera indicated that the onset ofthis abundant "late-stage" site ofE5 protein expression narrowly preceded or was concomitant with expression of nuclear viral capsid antigen. Moreover, well-differentiated regions of the wart that did not express capsid protein were also negative for abundant E5 protein synthesis. Such E5-positive cells occurred singly or in clusters, suggesting a sporadic induction ofBPV-1 gene expression in these permissive layers. This site of abundant E5 protein synthesis was thus spatially and temporally distinct from the site of maximal viral E2 protein synthesis that was observed typically in parabasal and lower spinous layer cells (Fig. 4c ) and that appears to coincide with the time of onset of vegetative BPV-1 DNA synthesis (21) . As with the basal cell site of E5 protein expression, the specificity of E5 immunofluorescent staining in well-differentiated permissive areas of the wart was confirmed by the lack of staining of the corresponding cell layers in normal bovine skin with E5 immune serum (Fig. 3f) and in the wart with preimmune serum (not shown) or with E5 peptide-blocked immune serum (Fig. 3h) . (22) . Our present findings suggest that the E5 protein also plays a role in the transformation of epithelial cells during papilloma formation and are consistent with the observation that the BPV-1 E5 gene expressed from a heterologous retrovirus promoter can induce tumorigenic transformation of an established line of murine keratinocytes (23) . It seems unlikely that the E5 protein transforms epidermal cells by virtue of its ability to activate PDGF-R, since keratinocytes do not appear to express the PDGF-R gene.
A number of human papillomavirus (HPV) types (HPV-6, -16, and -18) have the potential to encode short hydrophobic E5 proteins with limited homology to the BPV-1 E5 transforming protein (3, 24, 25), and it is therefore possible that these HPV ES genes are involved in the formation of papillomas in human epithelia. Indeed, it has recently been found that the HPV-16 E5 gene can induce tumorigenic transformation of established murine keratinocytes (23) , and the HPV-6 ES gene can morphologically transform murine NIH 3T3 cells in cell culture (26) . An attempt to localize the site of HPV-6 ES protein expression in HPV-6associated respiratory tract papilloma tissue by immunohistochemical analysis revealed diffuse cytoplasmic and nuclear staining throughout all of the suprabasal cell layers rather than cytoplasmic basal cell staining (27) . The basis for this different localization is unclear and may reflect the biological differences between BPV-1 and HPV-6.
The detection of abundant BPV-1 E5 protein in highly differentiated permissive keratinocytes in our study was unexpected and indicates that E5, in addition to its recognized role as a transforming gene, may also-function as one of a set of coordinately expressed late genes. This proposal would be consistent with the data of Baker and Howley (28) , who characterized abundant viral late cDNAs from produc-tively infected bovine fibropapilloma tissue. Several mRNA species transcribed from the BPV-1 late promoter contained an intact E5 open reading frame.
The role of the BPV-1 ES protein in viral maturation is unknown. Our results raise the possibility that synthesis of large amounts ofE5 protein alters the normal physiology ofthe host differentiated keratinocyte to promote viral DNA replication, capsid protein expression, or release ofinfectious virus particles. During the final stages of keratinocyte terminal differentiation in normal epidermis there is extensive protein filament cross-linking in addition to autodigestion of cytoplasmic organelles and nuclear contents. Perhaps interaction ofE5 with the 16-kDa component of the vacuolar proton-ATPase in terminally differentiated keratinocytes results in alteration of lysosomal pH, thereby affecting the activity of hydrolytic enzymes. Alternatively, the E5 protein might perform a function analogous or complementary to that of the E4 protein of certain HPV types that is abundantly expressed in permissive terminally differentiated keratinocytes (29, 30) . The HPV-16 E4 protein may function to induce collapse of the cytokeratin intermediate filament network in keratinocytes by directly interacting with keratin filaments (31) . Although BPV-1 E4-related antigens have been detected in productively infected bovine fibropapilloma tissue, they seem to be present at a comparatively low level (32) .
In conclusion, our observations raise the intriguing possibility that the ES protein has two functionally distinct roles in the BPV-1 infectious cycle in host epithelial cells. It remains to be determined if the E5 protein interacts with different or similar cellular targets in transformed basal epithelial cells and in permissive differentiated keratinocytes. The finding of a constitutively expressed transformation-associated viral antigen in the proliferating basal cells of a wart warrants investigation of the potential use of ES as a vaccine component in experimental animals. 
